Septocaine And Epinephrine Injection, Solution
Product Images NDC 0362-9049

5 FDA label images from Septodont Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Septocaine And Epinephrine (NDC 0362-9049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Septodont Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Articaine Structural Formula (Articaine HCl Molecule)

Articaine Structural Formula (Articaine HCl Molecule)
Chemical structure of Articaine Hydrochloride as the active ingredient in Septocaine and Epinephrine injection solution. The diagram shows the molecular arrangement including a thiophene ring and ester functional groups.*
FDA Label Image

Epinephrine Structural Formula (Epinephrine Bitartrate)

Epinephrine Structural Formula (Epinephrine Bitartrate)
Chemical structure diagram showing two distinct molecular structures likely representing the active ingredients Articaine Hydrochloride and Epinephrine Bitartrate in Septocaine and Epinephrine injection solution.*
FDA Label Image

Principal Display Panel (1.7 mL Cartridge Carton)

Principal Display Panel (1.7 mL Cartridge Carton)
Packaging label for Septocaine (articaine HCl and epinephrine) Injection, a submucosal injection solution with 4% articaine hydrochloride (40 mg/mL) and epinephrine 1:100,000 concentration. The label indicates 50 single-dose cartridges of 1.7 mL each. Manufactured for Septodont Inc. by Novocol Pharmaceutical of Canada. Includes storage instructions and NDC 0362-9049-02.*
FDA Label Image

Principal Display Panel (1.7 mL Cartridge)

Principal Display Panel (1.7 mL Cartridge)
Packaging label for Septocaine and Epinephrine Injection, solution for submucosal injection. Contains Articaine Hydrochloride 4% (40 mg/mL) and Epinephrine 1:200,000. Supplied as 50 single-dose cartridges of 1.7 mL each. Manufactured for Septodont Inc. by Novocol Pharmaceutical of Canada.*
FDA Label Image

Principal Display Panel (1.7ml Cartridge Ca)

Principal Display Panel (1.7ml Cartridge Ca)
Packaging label for Septocaine and Epinephrine Injection, a submucosal injection solution containing Articaine Hydrochloride 4% (68 mg/1.7 mL) and Epinephrine 1:100,000 (40 mcg/mL). The label indicates 50 single-dose cartridges of 1.7 mL each. Manufactured by Septodont in France and distributed by Septodont, Inc. in Lancaster, PA, the label includes storage instructions to keep at 25°C (77°F) and not to freeze, as well as warnings about sodium metabisulfite content.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.